Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

GeneDx Holdings (WGS) Accumulated Depreciation & Amortization: 2020-2025

Historic Accumulated Depreciation & Amortization for GeneDx Holdings (WGS) over the last 5 years, with Sep 2025 value amounting to $2.4 million.

  • GeneDx Holdings' Accumulated Depreciation & Amortization fell 0.91% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year increase of 531.20%. This contributed to the annual value of $7.9 million for FY2024, which is 59.90% down from last year.
  • Latest data reveals that GeneDx Holdings reported Accumulated Depreciation & Amortization of $2.4 million as of Q3 2025, which was up 4.35% from $2.3 million recorded in Q2 2025.
  • In the past 5 years, GeneDx Holdings' Accumulated Depreciation & Amortization ranged from a high of $30.6 million in Q4 2022 and a low of -$7.9 million during Q4 2023.
  • Its 3-year average for Accumulated Depreciation & Amortization is $2.2 million, with a median of $2.3 million in 2025.
  • As far as peak fluctuations go, GeneDx Holdings' Accumulated Depreciation & Amortization soared by 427.61% in 2022, and later tumbled by 125.97% in 2023.
  • Quarterly analysis of 5 years shows GeneDx Holdings' Accumulated Depreciation & Amortization stood at $5.8 million in 2021, then soared by 427.61% to $30.6 million in 2022, then plummeted by 125.97% to -$7.9 million in 2023, then skyrocketed by 125.19% to $2.0 million in 2024, then dropped by 0.91% to $2.4 million in 2025.
  • Its Accumulated Depreciation & Amortization stands at $2.4 million for Q3 2025, versus $2.3 million for Q2 2025 and $2.2 million for Q1 2025.